RIGL

RIGL

USD

Rigel Pharmaceuticals Inc. Common Stock

$28.380-1.710 (-5.683%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$30.090

Máximo

$30.795

Mínimo

$28.080

Volumen

0.31M

Fundamentos de la Empresa

Capitalización de Mercado

509.1M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.71M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $13.91Actual $28.380Máximo $43.72

Noticias Relacionadas

PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...

Ver más
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
CNBC

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

Ver más
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'
PR Newswire

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on...

Ver más
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update